Atlas Trials

A Phase I Study of BMS-275183 (Oral Taxane) Given on a Daily Schedule in Combination With Esomeprazole (Nexium) in Patients With Advanced Cancer

Clinical trial NCT00332748 · TERMINATED

Trial details

NCT number
NCT00332748
Sponsor
Bristol-Myers Squibb
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Cancer
Start date
2006-12-01
Primary completion
2007-12-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.